Aptevo Therapeutics Inc (APVO) - Financial and Strategic SWOT Analysis Review

Region:North America

Author(s):

Product Code:GDPH2536587FSA

Download Sample Report download
Buy the Full ReportStarting from $125
Published on

September 2018

Total pages

52

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $125

About the Report

About the Report

Aptevo Therapeutics Inc (APVO)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-Analyst's summarization of the company's business strategy.

- SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.

- Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

- Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Aptevo Therapeutics Inc (Aptevo), a subsidiary of Emergent Biosolutions Inc, is a biotechnology company that develops and commercializes oncology and hematology therapeutics. The company's only marketed product Ixinity that is indicated to replace the missing clotting factor IX in adults and children with hemophilia B. Its pipeline includes immune-oncology candidates for the treatment metastatic castration-resistant prostate cancer, peripheral T-cell lymphoma (PTCL), hematological malignancies, psoriasis and inflammatory bowel disease, and solid tumors. Aptevo is also developing a lead bispecific antibody candidate in collaboration with Alligator Bioscience AB for the treatment of various types of cancer. The company's immuno-oncology candidates are built on its proprietary Adaptir platform. Aptevo is headquartered in Seattle, Washington, the US.

Aptevo Therapeutics Inc Key Recent Developments

Aug 20,2018: Aptevo Therapeutics deploys Genedata Biologics to streamline Cancer Immunotherapy R&D

Aug 09,2018: Aptevo Therapeutics reports second quarter 2018 financial results

May 10,2018: Aptevo Therapeutics Reports First Quarter 2018 Financial Results

Mar 13,2018: Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update

Nov 09,2017: Aptevo Therapeutics Reports Third Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

- The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Products

Products

Aptevo Therapeutics Inc, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts


Companies

Bioverativ Inc

Amgen Inc

Biogen Inc

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Section 1-About the Company 6

Aptevo Therapeutics Inc-Key Facts 6

Aptevo Therapeutics Inc-Key Employees 7

Aptevo Therapeutics Inc-Key Employee Biographies 8

Aptevo Therapeutics Inc-Major Products and Services 9

Aptevo Therapeutics Inc-History 10

Aptevo Therapeutics Inc-Company Statement 11

Aptevo Therapeutics Inc-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 15

Company Overview 15

Aptevo Therapeutics Inc-Business Description 16

R&D Overview 16

Aptevo Therapeutics Inc-Corporate Strategy 17

Aptevo Therapeutics Inc-SWOT Analysis 18

SWOT Analysis-Overview 18

Aptevo Therapeutics Inc-Strengths 18

Aptevo Therapeutics Inc-Weaknesses 19

Aptevo Therapeutics Inc-Opportunities 20

Aptevo Therapeutics Inc-Threats 21

Aptevo Therapeutics Inc-Key Competitors 22

Section 3-Company Financial Ratios 23

Financial Ratios-Capital Market Ratios 23

Financial Ratios-Annual Ratios 24

Performance Chart 26

Financial Performance 26

Financial Ratios-Interim Ratios 27

Financial Ratios-Ratio Charts 28

Section 4-Company's Lifesciences Financial Deals and Alliances 29

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Aptevo Therapeutics Inc, Recent Deals Summary 31

Section 5-Company's Recent Developments 32

Aug 20, 2018: Aptevo Therapeutics deploys Genedata Biologics to streamline Cancer Immunotherapy R&D 32

Aug 09, 2018: Aptevo Therapeutics reports second quarter 2018 financial results 33

May 10, 2018: Aptevo Therapeutics Reports First Quarter 2018 Financial Results 35

Mar 13, 2018: Aptevo Therapeutics Reports 2017 Financial Results and Provides Business Update 37

Nov 09, 2017: Aptevo Therapeutics Reports Third Quarter 2017 Financial Results 39

Oct 02, 2017: Aptevo Therapeutics Presents New Data on Enhanced Features of Its Next Generation ADAPTIR Bispecific Platform at the World Bispecific Summit 41

Aug 29, 2017: ImmunoPrecise announces R&D success using the OmniAb platform to develop fully human antibodies 43

Aug 10, 2017: Aptevo Therapeutics Reports Second Quarter 2017 Financial Results 44

May 12, 2017: Aptevo Therapeutics Reports First Quarter 2017 Financial Results 45

May 05, 2017: Aptevo Therapeutics Presents Detailed Overview of its Adaptir Protein Therapeutic Platform at the 13th Annual Pegs Summit 47

Section 6-Appendix 48

Methodology 48

Ratio Definitions 48

About GlobalData 52

Contact Us 52

Disclaimer 52


List of Figure

List of Figures

Aptevo Therapeutics Inc, Performance Chart (2013-2017) 26

Aptevo Therapeutics Inc, Ratio Charts 28

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 30


List of Table

List of Tables

Aptevo Therapeutics Inc, Key Facts 6

Aptevo Therapeutics Inc, Key Employees 7

Aptevo Therapeutics Inc, Key Employee Biographies 8

Aptevo Therapeutics Inc, Major Products and Services 9

Aptevo Therapeutics Inc, History 10

Aptevo Therapeutics Inc, Other Locations 14

Aptevo Therapeutics Inc, Subsidiaries 14

Aptevo Therapeutics Inc, Key Competitors 22

Aptevo Therapeutics Inc, Ratios based on current share price 23

Aptevo Therapeutics Inc, Annual Ratios 24

Aptevo Therapeutics Inc, Annual Ratios (Cont...1) 25

Aptevo Therapeutics Inc, Interim Ratios 27

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 29

Aptevo Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 30

Aptevo Therapeutics Inc, Recent Deals Summary 31

Currency Codes 48

Capital Market Ratios 48

Equity Ratios 49

Profitability Ratios 49

Cost Ratios 50

Liquidity Ratios 50

Leverage Ratios 51

Efficiency Ratios 51

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022